Vanda Pharmaceuticals
VNDA
VNDA
144 hedge funds and large institutions have $198M invested in Vanda Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 59 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
41% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 32
46% less call options, than puts
Call options by funds: $326K | Put options by funds: $609K
Holders
144
Holding in Top 10
–
Calls
$326K
Puts
$609K
Top Buyers
| 1 | +$6.18M | |
| 2 | +$4.85M | |
| 3 | +$2.44M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.79M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$1.76M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$8.1M | |
| 3 | -$3.52M | |
| 4 |
Millennium Management
New York
|
-$2.32M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$1.81M |